|
|
| thai fda gmp | 5 |  | 3.01 |
| ÁÍ¡.264-2521 ¢éÍ¡Ó˹´ | 5 | | 3.01 |
| »ÃСÒÈ¡ÃзÃǧÊÒ¸ÒóÊØ¢ ©ºÑº·Õè 136 àÃ×èͧ«ÍÊ»ÃاÃÊ. | 4 | | 2.41 |
| future magazine | 3 | | 1.81 |
| ÊÒÃàÃè§à¹×éÍá´§ã¹ÊØ¡Ã | 3 | | 1.81 |
| à´¡«ì«ÒàÁ¸Ò⫹¤×Í | 3 | | 1.81 |
| ¡ÅÂØ·¸ì·Ò§¡ÒõÅÒ´¹Á Ê´ ¾ÒÊ à¨ÍÃì äà «ì | 3 | | 1.81 |
| medical device post market surveillance | 3 | | 1.81 |
| »ÃСÒÈÊӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ àÃ×èͧ¡ÒèѴãËéÁÕá¼è¹»éÒ¤Óàµ×͹ | 3 | | 1.81 |
| ¢éÍ¡Ó˹´ ÁÍ¡.57-2530 | 3 | | 1.81 |
| âç¼ÅÔµàÊ鹡ëÇÂàµÕëÂÇ㹡Ãا෾ËÃ×Í»ÃÔÁ³±Åʶҹ·ÕèµÑé§ áÅЪ×èÍâç§Ò¹¼ÅÔµ | 2 | | 1.20 |
| áËÅ觫×éÍá»é§¶ÑèÇàËÅ×ͧ | 2 | | 1.20 |
| ÇÔ¸Õ¡ÒÃÊ׺¤é¹¢éÍÁÙÅ | 2 | | 1.20 |
| ¡¯ËÁÒ·ҧ Í â«à´ÕèÂÁ àÁµÒ享ÑÅ俵ì | 2 | | 1.20 |
| ¾¹Ô´Ò ÇÂÑÁËÊØÇÃó | 2 | | 1.20 |
| â¦É³ÒÊØÃÒ and àÂÒǪ¹ | 2 | | 1.20 |
| ¤Ø³ÊÁºÑµÔ¢Í§ÂÒ aspirin | 2 | | 1.20 |
| ÊÒÃËéÒÁãªé ÍÂ. | 2 | | 1.20 |
| ÁҵðҹÍÒËÒà 264-2521 | 2 | | 1.20 |
| ÂÒ ors | 2 | | 1.20 |
| ÍسËÀÙÁÔ·ÕèàËÁÒÐÊÁ ¡Ò÷ʹäÊé¡ÃÍ¡ | 2 | | 1.20 |
| gmp | 2 | | 1.20 |
| ࡳ±ì jci | 2 | | 1.20 |
| ÁÍ¡.929-2533 | 2 | | 1.20 |
| silver-haired bat ËÁÒ¶֧ | 1 | | 0.60 |
| âçàÃÕ¹ÁÒÃÕÇÔ·ÂÒ¡ºÔ¹·ÃìºØÃÕ | 1 | | 0.60 |
| ¡¯ËÁÒÂãËÁè ʤº àÃ×èͧ¡ÒäԴ¤èÒä¿¿éÒÂé͹ËÅѧ | 1 | | 0.60 |
| ¨Ø´à¡Ô´¤ÃѹÊÙ§ | 1 | | 0.60 |
| äÁèÃÙéÇèÒµÑ駤ÃÃÀì¡Ô¹¡ÅÙµÒä¸â͹ä»ÍѹµÃÒµèÍà´ç¡ã¹¤ÃÃÀì | 1 | | 0.60 |
| ¤ÃÕÁqian li | 1 | | 0.60 |
| ÃéÒ¹¢ÒÂÂÒ˹éÒâç¾ÂÒºÒÅÈÔÃÔÃÒª | 1 | | 0.60 |
| sodium hydrosulfite ËÁÒ¶֧ÍÐäà | 1 | | 0.60 |
| ÃÒª×èͤÃÕÁ·Õè ÍÂ. ËéÒÁ | 1 | | 0.60 |
| ¡Òà ¼ÅÔµ ÍÒËÒà ¡Ãлëͧ | 1 | | 0.60 |
| ÁÍ¡.264-2521 | 1 | | 0.60 |
| Â×´¼Áá¾éà»ç¹ÊÔǼ×è¹á¾é | 1 | | 0.60 |
| ºÃóҹءÃÁ ªÑ¹ÊٵþÅԡȾ | 1 | | 0.60 |
| èÊÒÂÊд×Í | 1 | | 0.60 |
| ¤ÙèÁ×Í¡ÒõÃǨ»ÃÐàÁԹʶҹ·Õè¼ÅÔµÂÒá¼¹»Ñ¨¨ØºÑ¹µÒÁËÅѡࡳ±ìÇÔ¸Õ¡Ò÷Õè´Õ㹡ÒüÅÔµÂÒ (gmp) | 1 | | 0.60 |
| ¤ÇÒÁ¨ØÎÒÃì´´ÔÊ | 1 | | 0.60 |
| Ê׺¤é¹¢éÍÁÙÅ¡ÒÃãªéËéͧÊÁØ´ | 1 | | 0.60 |
| ¤ÇÒÁËÁÒ nsaids | 1 | | 0.60 |
| »ÃСÒÈ¡ÃзÃǧÊÒ¸ÒóÊØ¢ ©ºÑº·Õè 184 »Õ ¾.È2546 | 1 | | 0.60 |
| ÃéÒ¹à¡ÕêÂÇ«èÒ | 1 | | 0.60 |
| cantralidin | 1 | | 0.60 |
| ºÃÔÉÑ·àªè§ àÎÕ§ ÎÇ´ àÁÅ紾ѹ¸Øì | 1 | | 0.60 |
| cetriazone | 1 | | 0.60 |
| david a. carpenter liability and claims volume 2 | 1 | | 0.60 |
| Ãкºgmp¨Ó¹Ç¹Ëéͧ¹éÓ | 1 | | 0.60 |
| ºÃÔ¡ÒÃàºÒËÇÒ¹ | 1 | | 0.60 |
| âäà¡ÕèÂǡѺàª×éÍâ»Ã൫ÑÇ | 1 | | 0.60 |
| ࡳ±ì»ÃÐàÁÔ¹ ¨Õ.àÍçÁ.¾Õ. | 1 | | 0.60 |
| ÇÔ¸Õ¡ÒÃãªé à¤Ã×èͧÊÓÍÒ§¨Ñ¹·ÃìÊÇèÒ§ | 1 | | 0.60 |
| ÃдѺ¤ÇÒÁËÇÒ¹ sorbitol | 1 | | 0.60 |
| àÁ·Ò¹ÍÅ â¤Ã§ÊÃéÒ§ | 1 | | 0.60 |
| gà¤Ã×èͧÊÓÍÒ§·ÕèÁÕÍѹµÃÒµͼÔÇ˹éÒ | 1 | | 0.60 |
| ¨Ñ´ÃÐàºÕºãËéâµêзӧҹ ¨ØÌÒ | 1 | | 0.60 |
| ºÃÔÉÑ·¼ÅÔµÍÒËÒÃáÅÐÂÒ | 1 | | 0.60 |
| áªÁ¾Ù»ÅÍÁ | 1 | | 0.60 |
| sunscreen ÂÕèËéÍä˹´Õ | 1 | | 0.60 |
,
User's Guide
˹éÒÅçÍ¡ÍÔ¹| ʶԵÔÃÒ»Õ
| ʶԵÔÃÒÂà´×͹
| ʶԵÔÃÒÂÇѹ
| ʶԵÔÃÒªÑèÇâÁ§
| Eng
Pageview 
Unique IPs 
Sessions